LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 16 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ethos Financial Group, LLC | 248,084 | $205,240 | 0.06% |
| EP Wealth Advisors, LLC | 2,211 | $785,836 | 0.01% |
| Northeast Financial Consultants Inc | 20,000 | $16,546 | 0.00% |
| UBS Group AG | 10,722 | $8,867 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 24,901 | $20,601 | 0.00% |
| WELLS FARGO & COMPANY/MN | 53 | $44 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 101,209 | $84,003 | 0.00% |
| STATE STREET CORP | 35,956 | $29,843 | 0.00% |
| MORGAN STANLEY | 71,054 | $58,783 | 0.00% |